Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
600 participants
OBSERVATIONAL
2020-01-01
2024-02-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy
NCT02643199
5D Versus Conventional 2D Fetal Echocardiography During Second Trimester of Pregnancy
NCT02675595
Fetal Brain Ultrasound
NCT06410391
FGR Diagnostic Criteria in Predicting Adverse Neonatal Outcomes
NCT04933396
Assessment of Cardiac Sparing in Fetal Hypoxia
NCT03146507
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Extended fetal heart examination
Fetal echocardiography
fetal heart examination by medical ultrasound
B
Modified extended heart examination
Fetal echocardiography
fetal heart examination by medical ultrasound
C
Sief\_Twist sign only examination
Fetal echocardiography
fetal heart examination by medical ultrasound
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fetal echocardiography
fetal heart examination by medical ultrasound
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. gestational age 14-37 weeks.
3. no maternal medical disorder .
4. no morbed obisity.
Exclusion Criteria
2. chorioamnionitis.
3. fetal anomalies.
4. abnormal fetal karyotype
5. patient withdrawal from the study and/or unavailability for follow-up.
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sief el eslam Ahmed Ali
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUE202010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.